IL6 and cancer: The median ALC and lymphocyte subsets (CD3, CD4, CD8, Treg, NK and B cells) were significantly lower in cancer patients, while median fibrinogen levels (p < 0.001) and IL‐6 (p < 0.001) were significantly higher in cancer cohort.